The role of bacterial lysates in the treatment of respiratory diseases

Abstract

Over 40% of adults in Russia suffer from immune system imbalance associated with atypical, protracted and recurrent course of respiratory infections. Drug treatment as part of the complex therapy largely depends on the state of the immune system. Decrease of the immune function results in lower efficiency of etiotropic therapy. Th specific course of respiratory diseases today and new data on the immune system make selection of the effective drug for immune correction a relevant issue. Nonspecific prevention of respiratory tract infections with immunomodulators, including bacterial lysates, is a matter of increasing scientific interest. Broncho-Vaxom is one of such medications which reduces the incidence of acute respiratory infections, as well as the number of exacerbations of chronic inflammatory diseases of the upper and lower respiratory tract. Broncho-Vaxom's safety profile is comparable to placebo.

Keywords

• ори
• профилактика
• бактериальные лизаты
• бронхо-ваксом
• ari
• prevention
• bacterial lysates
• broncho-vaxom